Immunome
IMNM
$6.20
Share price
-0.16%
Change (1 day)
-69.50%
Change (1 year)
Categories
Immunome (IMNM) - Cash on Hand
Cash on Hand as of December 2024 : $0.21 Billion USD
According to Immunome's latest financial reports the company has $0.21 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunome - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $0.21 B | 57.3% |
| 2023-12-31 | $0.13 B | 579.73% |
| 2022-12-31 | $20.32 M | -58.72% |
| 2021-12-31 | $49.22 M | 23.8% |
| 2020-12-31 | $39.76 M | 1463.74% |
| 2019-12-31 | $2.54 M | 58.74% |
| 2018-12-31 | $1.6 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | $0.25 B | 17.79% | 🇺🇸 USA |